Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Facebook
Twitter
Pinterest
Telegram
Linkedin
WhatsApp
Matérias relacionadas
Comentários
Deixe um comentário
Todos os campos são requeridos
Mais vistas
- Beryl, a segunda tempestade tropical da temporada
- Díaz-Canel avalia o desenvolvimento da província de Artemisa
- Cuba busca cinco medalhas de ouro em Paris com cerca de 60 atletas em 16 esportes
- Ministro das Relações Exteriores de Cuba rejeita mandado de prisão para o presidente sírio
- Cuba evoca a descoberta dos restos mortais de Che Guevara
